07th week of 2012 patent applcation highlights part 45 |
Patent application number | Title | Published |
20120041024 | QUINOLYL AMINES AS KINASE INHIBITORS - Disclosed are compounds having the formula: | 2012-02-16 |
20120041025 | Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof - Compounds are provided that comprise dinitroso-derivatives of dihydrolipoic acid. Pharmaceutical compositions comprising the compounds and methods of using the compounds for treating various diseases and disorders, including angina, hypertension, diabetes, dyslipidemia, renal insufficiency, myocardial infarction, stroke, atherosclerosis, and the target organ damage that accompanies these various diseases and disorders, are further provided. The compounds are useful in improving vasodilation, reducing low-density lipoprotein oxidation, and reducing inflammation in a subject. | 2012-02-16 |
20120041026 | (R)-4-((4-((4-(TETRAHYDROFURAN-3-YLOXY)BENZO[D]ISOXAZOL-3-YLOXY)METHYL)PIP- ERIDIN-1-YL)METHYL)TETRAHYDRO-2H-PYRAN-4-OL, A PARTIAL AGONIST OF 5-HT4 RECEPTORS - (R)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol and its use in treating neurodegenerative disorders, is described herein. | 2012-02-16 |
20120041027 | BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE - Compounds of formula (I) and salts and solvates are provided: | 2012-02-16 |
20120041028 | BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE - Compounds of formula (I), salts and solvates are provided: | 2012-02-16 |
20120041029 | COMPOSITIONS FOR DRUG DELIVERY - Substantially non-porous polymeric microparticles comprising a hydrophobic polymer and a plasticizer, and containing therein a bioactive or bioinactive agent. | 2012-02-16 |
20120041030 | PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION - Disclosed are a novel pyridine thio derivative, and a pharmaceutical composition using the novel pyridine thio derivative, particularly a pharmaceutical composition having selective antibacterial activity against | 2012-02-16 |
20120041031 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS - Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha 2 receptor agonist. | 2012-02-16 |
20120041032 | METALLOPROTEIN INHIBITORS - The present invention relates to metalloprotein inhibitors comprising: a. an organic substituent and at least one zinc binding group (ZBG) covalently attached thereto; or b. a ZBG substituted by a side chain wherein the ZBG is of formula (I): wherein X is O or S and each R | 2012-02-16 |
20120041033 | HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS - Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form. | 2012-02-16 |
20120041034 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION - A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases. | 2012-02-16 |
20120041035 | LEVAMLODIPINE COMPOUND PHARMACEUTICAL COMPOSITION - A levamlodipine compound pharmaceutical composition is provided, which contains levamlodipine or a pharmaceutically acceptable salt thereof, and chlorthalidone. In the present invention, levamlodipine and chlorthalidone are administrated in combination for treating hypertension, a high synergistic antihypertensive effect is achieved, and the edema side effect due to sodium and water retention caused when levamlodipine is administrated alone is mitigated. In addition, levamlodipine increases insulin sensitivity of an organism, and resists the side effect of increase in blood glucose level caused by chlorthalidone. The pharmaceutical composition of levamlodipine and chlorthalidone overcomes the disadvantage that levamlodipine takes effects slowly in hypertension repression. | 2012-02-16 |
20120041036 | SUBSTITUTED ACYLGUANIDINE DERIVATIVES (AS AMENDED) - An object of the present invention is to provide an excellent agent for treating or preventing dementia, schizophrenia based on serotonin 5-HT | 2012-02-16 |
20120041037 | COMPOSITION THAT COMPRISES AT LEAST ONE OXIME AND ITS USE IN THERAPEUTICS - A medication, a pharmaceutical composition, and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT). | 2012-02-16 |
20120041038 | AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS - Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions. | 2012-02-16 |
20120041039 | AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS - Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions. | 2012-02-16 |
20120041040 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3-DIPOLAR CYCLOADDITION AND POLYMERS THEREOF - The present invention provides novel functionalized mixtures 4- and 5-vinyl substituted regioisomers of 1,2,3-triazoles via 1,3-dipolar cycloaddition. Functionalized alkyne moieties with a terminal alcoholic functionality are reacted with functionalized organic moieties with a terminal leaving group and an azide to provide an alcoholic functionalized mixture of 4- and 5-substituted regioisomers of 1,2,3-triazole moieties. The mixture may be converted to a wide variety of useful functionalized mixtures of 4- and 5-vinyl substituted regioisomers of 1,2,3-triazole moieties, which in turn can be converted to a wide variety of useful polymers The novel alcoholic functionalized mixtures of 4- and 5-substituted regioisomers can be separated by chromatography to provide the purified 4- and 5-alcoholic functionalized substituted 1,2,3-triazole moieties. The novel compounds of the invention can be employed in a wide variety of compositions (Formulae (I), (II)); wherein R | 2012-02-16 |
20120041041 | 5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY - Compounds of formula (I) in free or salt or solvate form, wherein T has the meaning as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the β | 2012-02-16 |
20120041042 | Scent Ectoparasiticidal Formulation - The present invention provides an improved-scent composition comprising metaflumizone, as well as a method for protecting against ectoparasite infestations in a warm-blooded animal. | 2012-02-16 |
20120041043 | Sulfonamide Compounds for the Treatment of Respiratory Disorders - Compounds of formula (I) are agonists of PPARγ, useful for the treatment of respiratory disease; formula (I): wherein R | 2012-02-16 |
20120041044 | PROCESS FOR THE PREPARATION OF CARVEDILOL AND ITS ENANTIOMERS - The present invention relates to a process for the preparation of carvedilol as well as of the optically active R and S enantiomers thereof and of mixtures of these enantiomers and, more particularly, relates to an improved process for the preparation of carvedilol and its enantiomers characterized by the use of ethyl acetate as reaction solvent. | 2012-02-16 |
20120041045 | USE OF PHARMACEUTICAL COMPOSITIONS CONTAINING MESEMBRENONE - The use of mesembrenone and medicaments and dietary supplements containing mesembrenone. The applicant has surprisingly found that mesembrenone exhibits potent PDE-4 inhibition properties and, in addition to being useful in treating conditions that respond to treatment with a PDE-4 inhibitor, has dual activity on account of its serotonin-uptake inhibition properties. Mesembrenone is extracted and isolated, for example as a pure compound, from plant material of the plant family Mesembryan-themaceae. Preferably a plant or plants from the genus | 2012-02-16 |
20120041046 | NON-STEROIDAL COMPOUNDS FOR ANDROGEN RECEPTOR MODULATION - The present invention concerns compounds of general Formula (I): method of preparation and uses thereof. | 2012-02-16 |
20120041047 | Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions - This invention relates to a pharmaceutical composition for the treatment and/or prevention of at least one pathological neovascularization-related conditions of the interior of the eye, the composition comprising a therapeutically effective amount of an antisense oligonucleotide having the sequence SEQ ID NO: 1: | 2012-02-16 |
20120041048 | COMPOSITIONS AND METHODS RELATING TO miR-31 - MicroRNA-31 (miR-31), targets of miR-31, the role of miR-31 in inhibiting tumor metastasis, and the role of miR-31 target genes in promoting tumor metastasis are disclosed. | 2012-02-16 |
20120041049 | DESIGN OF SMALL-INTERFERING RNA - The present invention relates to small-interfering RNA molecules displaying an increased thermodynamic stability at the 3′ end of the antisense strand (guide strand) and the 5′ end of the sense strand (passenger strand), respectively, in comparison to the base pairing in the seed region. The siRNAs of the present invention display an increased knock-down activity against targeted genes and show an improved resistance to RNAses, in particular serum RNAses. The present invention also relates to a method for the production of the siRNA molecules, a method of target-specific RNA interference making use of the improved siRNA molecules of the invention and pharmaceutical compositions containing the siRNA molecules. | 2012-02-16 |
20120041050 | ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF - An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 202. | 2012-02-16 |
20120041051 | Compositions And Methods For Inhibiting Expression Of MIG-12 Gene - The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting MIDI interacting G12-like protein (MIG 12) gene, and methods of using the dsRNA to inhibit expression of MIG 12. | 2012-02-16 |
20120041052 | Compositions and Methods to Treat Muscular & Cardiovascular Disorders - The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2. | 2012-02-16 |
20120041053 | DELIVERY OF dsRNA TO ARTHROPODS - The invention is to methods of gene silencing in arthropods using dsRNA. The method is include contacting the arthropod with, and/or directly feeding the arthropod, the dsRNA to the arthropods to deliver the dsRNA to arthropod tissues. It is envisaged that the methods of the invention will have use in determining the biological function of genes in arthropods. Methods of pest control of arthropods, and of protecting arthropods against parasites and predators are provided. Transgenic arthropods expressing dsRNA molecules are also provided by the present invention. | 2012-02-16 |
20120041054 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS AND OTHER DISORDERS INVOLVING PHOSPHOLIPASE A2 INDUCTION - The present invention provides antisense oligomers to PLA | 2012-02-16 |
20120041055 | COMPOSITE POLYNUCLEIC ACID THERAPEUTICS - Compositions comprising therapeutic polynucleic acids and method of use. The compositions comprise one or more polynucleic acid sequences having two or more features useful for treating diseases associated with cellular proliferation or growth. | 2012-02-16 |
20120041056 | NUCLEIC ACIDS SPECIFICALLY BINDING WITH HUMAN FACTOR VII/VIIA AND USES THEREOF - A nucleic acid includes at least 15 nucleotides with a length specifically binding with the human factor VII/VIIa. | 2012-02-16 |
20120041057 | SYNTHESIS AND CHARACTERIZATION OF C8 ANALOGS OF c-di-GMP - The invention provides analogs cyclic diguanosine monophosphate (c-di-GMP) having different substituents at the guanine C8 position. | 2012-02-16 |
20120041058 | COMPOSITION OF TRADITIONAL CHINESE MEDICINE FOR REDUCING BLOOD FAT AND PREPARATION METHOD THEREOF - Composition of traditional Chinese medicine for reducing blood lipid with components of the crude drug of artemisinins and the crude drug of ursolic acid, wherein the ratio of the crude drug of artesunate and the crude drug of ursolic acid is 1:25-25:1 by weight. The preparation method of such composition includes the following steps: the crude drug of artesunate and the crude drug of ursolic acid are mixed at the weight ratio mentioned above, comminuted, then screened through 120 mesh sieve to obtain the composition; or the crude drug of artesunate and the crude drug of ursolic acid are weighed at the weight ratio mentioned above, comminuted, screened through 120 mesh sieve separately, then mixed and screened for three times to obtain the composition. The composition of the present invention can be formulated into formulations for injection, oral administration with pharmaceutically acceptable carriers, and can be used for preparing medicaments for reducing blood lipid. | 2012-02-16 |
20120041059 | BIOACTIVE COMPOSITIONS FROM THEACEA PLANTS AND PROCESSES FOR THEIR PRODUCTION AND USE - The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant. | 2012-02-16 |
20120041060 | TREATMENT FOR ALTITUDINAL HYPOXIA - The invention provides a method for treating hypoxia caused by high altitude by administering to a subject a compound that reduces the P | 2012-02-16 |
20120041061 | USE OF PRODRUGS OF GABA ANALOGS FOR TREATING DISEASES - Methods of using prodrugs of GABA analogs and pharmaceutical compositions thereof to treat migraine, fibromyalgia, amyotrophic lateral sclerosis, irritable bowel syndrome, social phobia, Parkinson's disease, asthma, cough, or chronic obstructive pulmonary disease, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating migraine, fibromyalgia, amyotrophic lateral sclerosis, irritable bowel syndrome, social phobia, Parkinson's disease, asthma, cough, or chronic obstructive pulmonary disease are disclosed. | 2012-02-16 |
20120041062 | COMPOUND OF SALVIANOLIC ACID L, PREPARATION METHOD AND USE THEREOF - The present invention relates to a new compound of salvianolic acid L, its preparation method, a pharmaceutical composition containing the salvianolic acid L, and its use for preparing a medicament for treating cardio-cerebrovascular diseases. | 2012-02-16 |
20120041063 | ANTITUMORAL COMPOUNDS -
A compound of general formula (I)
| 2012-02-16 |
20120041064 | SKIN TREATMENT - The present invention relates generally to the cosmetic treatment of aged skin. More specifically, the invention relates to the use of ingenol compounds, particularly ingenol angelates, in treating photo-aged and/or chronologically-aged skin. | 2012-02-16 |
20120041065 | LAURIC ACID DISTILLATE FOR ANIMAL FEED - Provided are novel methods and formulations for enhancing feed efficiency and reducing mortality in food animals. | 2012-02-16 |
20120041066 | MEDICAL FOODS FOR THE TREATMENT OF DEVELOPMENTALLY-BASED NEUROPSYCHIATRIC DISORDERS VIA MODULATION OF BRAIN GLYCINE AND GLUTATHIONE PATHWAYS - Describe herein are medical foods, pharmaceutical compositions, methods of compounding them, and method of using them for the treatment of developmentally-based neuropsychiatric disorders including particularly autism, ADHD, and persistent developmental disorders. The medical foods and pharmaceutical compositions typically include a methylglycine compound or precursor compound and an acetylcysteine compound or precursor compound. These methylglycine and acetylcysteine compounds may be prepared for sustained release or delivery. In some variations, a method of treating a developmentally-based neuropsychiatric disorder includes first determining if a patient is at risk for such a disorder by examining either or both phenotypical and genotypical biomarkers. The biomarkers may be used to tailor the dose to be delivered by the medial food or pharmaceutical composition. | 2012-02-16 |
20120041067 | Methods of Inducing Terminal Differentiation - The present invention provides methods of selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells, and/or inhibiting histone deacetylase (HDAC) by administration of pharmaceutical compositions comprising potent HDAC inhibitors. The oral bioavailability of the active compounds in the pharmaceutical compositions of the present invention is surprisingly high. Moreover, the pharmaceutical compositions unexpectedly give rise to high, therapeutically effective blood levels of the active compounds over an extended period of time. The present invention further provides a safe, daily dosing regimen of these pharmaceutical compositions, which is easy to follow, and which results in a therapeutically effective amount of the HDAC inhibitors in vivo. | 2012-02-16 |
20120041068 | Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility - An extended release preparation of an active pharmaceutical ingredient with pH dependent solubility dissolved or dispersed in a semi-solid or liquid nonionic solubilizer and further containing a non-pH dependent sustained release agent as well as a process for the preparation thereof are provided. | 2012-02-16 |
20120041069 | SGLT2 INHIBITOR DOSAGE FORMS - A pharmaceutical composition comprising a sodium-dependent glucose transporter (SGLT2) inhibitor and a biguanide, wherein at least one of the active agents is in slow release form, is provided. A method for treating diabetes in a patient in need thereof including administering an anti-diabetic combination comprising a sodium-dependent glucose transporter (SGLT2) inhibitor and a biguanide, wherein at least one of the active agents is in slow release form, is also provided. | 2012-02-16 |
20120041070 | METHODS OF TREATING CANCER HAVING AN ABERRANT EGFR OR KRAS GENOTYPE - The invention relates to the treating cancer having an aberrant EGFR or KRAS genotype, with an AMPK activator, as well as related methods, compounds and compositions. | 2012-02-16 |
20120041071 | TAPENTADOL FOR TREATING PAIN DUE TO OSTEOARTHRITIS - The use of tapentadol for treating pain due to osteoarthritis. | 2012-02-16 |
20120041072 | Antiviral agent - A compound having inhibitory activity on the binding of a substance α to a PTGS suppressor protein, wherein the substance α has a property of inducing PTGS and a property of binding to the PTGS suppressor protein and shows a decrease in the property of inducing PTGS upon binding to the PTGS suppressor protein. | 2012-02-16 |
20120041073 | STABILIZED MUTANT OPSIN PROTEINS - Methods and compositions for stabilizing opsin protein in a vertebrate visual system are provided by administration of opsin-binding synthetic retinoids. | 2012-02-16 |
20120041074 | Method of inducing neovascularization - A method for inducing neovascularization in which a pharmaceutically effective amount of polyethylene glycol (PEG) is injected into the tissue of the subject for purposes of accelerating wound healing and mimicking age related macular degeneration, cancer, tumors, and atherosclerosis for further research purposes. | 2012-02-16 |
20120041075 | ETHANOL COMPOSITIONS - In one embodiment, the present invention is to an ethanol composition comprising at least 85 wt. % ethanol and from 95 wppm to 850 wppm isopropanol. | 2012-02-16 |
20120041076 | GEL FORMING SOLUTION AND METHOD FOR PRODUCING GEL - A method for producing a gel includes a liquid droplet ejection step in which a first liquid is ejected in the form of a droplet to a second liquid to allow the first liquid and the second liquid to react with each other, thereby producing a gel. The first liquid is a gel forming solution containing an alcohol-based solvent, wherein the alcohol-based solvent is contained therein in an amount of 4% or more by weight and less than 70% by weight of the total amount of the gel forming solution. | 2012-02-16 |
20120041077 | ORGANOLEPTIC COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS - The present invention a method of improving, enhancing or modifying a fragrance formulation through the addition of an olfactory acceptable amount of the following compound: | 2012-02-16 |
20120041078 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER - The present invention includes methods of stabilizing one or more sweet enhancers when they are exposed to a light source as well as liquid compositions containing one or more sweet enhancers and one or more photostabilizers. | 2012-02-16 |
20120041079 | DEXTRAN FUNCTIONALIZED BY HYDROPHOBIC AMINO ACIDS - Dextran of the following general formula I: | 2012-02-16 |
20120041080 | CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM - This invention relates a cellulose solution comprising cellulose and at least one tetraalkylammonium alkylphosphate and processes to produce the cellulose solution. Another aspect of this invention relates to shaped articles prepared from a cellulose solution comprising cellulose and at least one tetraalkylammonium alkylphosphate. Another embodiment of this invention relates to compositions comprising derivatives of cellulose prepared from a cellulose solution comprising at least one tetraalkylammonium alkylphosphate. Another embodiment of this invention relates to compositions comprising regioselectively substituted cellulose esters prepared from a cellulose solution comprising cellulose and at least one tetraalkylammonium alkylphosphate. In another embodiment of the invention, the cellulose esters of the present invention are used as protective and compensation films for liquid crystalline displays. | 2012-02-16 |
20120041081 | Biogenic Silica from Silica-Containing Plant Material Such as Rice Hulls - A biogenic silica from a plant material such as rice hulls, rice straw and so forth containing a significant amount of silica for use as an anti-caking agent, excipient or flavor carrier. When the plant material is certified as organic, the silica may also be certified as organic. The plant material is ground and the silica may be concentrated by carbon reduction through enzymatic treatment or burning. In some instances an antimicrobial treatment of the silica may be beneficial. | 2012-02-16 |
20120041082 | METHODS OF USING SMAD3 AND JAK2 GENETIC VARIANTS TO DIAGNOSE AND PREDICT INFLAMMATORY BOWEL DISEASE - Disclosed are methods of diagnosing Inflammatory Bowel Disease by determining the presence or absence of genetic variants at SMAD3 and/or JAK2 loci. Provided is a method of diagnosing a Crohn's Disease subtype in an individual by determining the presence or absence of a risk variant at the SMAD3 and/or JAK2 loci. | 2012-02-16 |
20120041083 | SILICON OR ELEMENTARY METALS AS ENERGY CARRIERS - A method for providing storable and transportable energy carriers ( | 2012-02-16 |
20120041084 | Carboxylated Polymers of Intrinsic Microporosity (PIMs) with Tunable Gas Transport Properties - A film of a carboxylated polymer of formula (I): wherein the sum of x, y and z is an integer from 10 to 10,000 and degree of hydrolysis is 0.05 or greater provides gas separation materials in which the degree of hydrolysis may be used to tune the selectivity of the gases to an optimal required range. Such films may be prepared by casting a film of a polymer of formula (II): wherein n is an integer from 10 to 10,000, and hydrolyzing all or a portion of the —CN groups to form —COOH groups. | 2012-02-16 |
20120041085 | EXPANDABLE COMPOSITE RESIN PARTICLES FOR LONG-TERM STORAGE, PRE-EXPANDED PARTICLES FORMED THEREFROM AND EXPANDED MOLDED ARTICLES - Expandable composite resin particles for long-term storage, comprising 500 to 5000 ppm of water and 7.5 to 11.0% by weight of pentane in composite resin of polyolefin-based resin and polystyrene-based resin. | 2012-02-16 |
20120041086 | EXPANDABLE PELLETIZED MATERIALS BASED ON POLYESTER - An expandable pelletized material comprising
| 2012-02-16 |
20120041087 | Dry mixture for manufacturing cellular fibro concrete and method thereof - A dry raw mixture for manufacturing cellular fibro-concrete comprises components preferably in the following ratio: Portland cement 20-75%, mineralogical additives 70-20%, microsilica 2-10%', super-plastifier 0.6-3%, polypropylene fiber 0.08-0.15%, pore former 0.002-0.65%, and modifying ceolite additive 2-10%. The mineralogical additives can be represented by: fly ashes from coal combustion, ashes and slag, silica sand, limestone, and any combination thereof. The pore former can be represented by aluminum powder. The structure of modifying ceolite additive includes tetrahedrons SiO2 and AlO4. The raw mixture is further subjected to -intermingling and grinding in a conventional thin-powder grinder/mechanical activator, -bringing the mixture to a construction site, and -adding water to the mixture, thereby obtaining cellular fibro concrete. The method allows: -obtaining uniform mixtures, accelerating the hardening phase, -reducing costs due to avoiding the use of autoclave, steaming, and thermal curing equipment, -deploying inexpensive equipment for mixing concrete. | 2012-02-16 |
20120041088 | FOAMING ADDITIVE FOR PRODUCING POLYURETHANE FOAM, AND METHOD FOR PRODUCING RIGID POLYURETHANE FOAM BY USING IT - To provide a foaming additive for producing a polyurethane foam, which is capable of solving a problem of deterioration of moldability due to deterioration of the initial foaming property of a foam, and a method for producing a rigid polyurethane foam by using it. | 2012-02-16 |
20120041089 | POLYOL FORMED FROM AN EPOXIDIZED OIL - A polyol includes the reaction product of an epoxidized oil and an organic acid. The epoxidized oil and the organic acid are reacted in the presence of a Lewis base catalyst including at least one of a phosphorous atom or a nitrogen atom. The polyol is formed by a method that includes the step of reacting the epoxidized oil with the organic acid in the presence of the Lewis base catalyst. | 2012-02-16 |
20120041090 | PROCESS FOR PREPARING A FLEXIBLE POLYURETHANE FOAM - The process comprises preparing a reaction mixture from a polyisocyanate component and from a polyol component which comprises one or more polyester polyols formed from at least one dimer fatty acid and/or at least one dimer fatty alcohol. In order to improve the processability of the polyurethane flexible foams so that these foams can be produced with the desired hardness and mechanical properties over a broad density range, the isocyanate reactive compounds contain, per 100 parts by weight thereof, 25 to 95 parts by weight of said polyester polyols and 5 to 75 parts by weight of one or more polyether polyols which are free of dimer fatty chains. In this way, no lipophilic filler is needed so that the fogging and emission properties of the foam can be improved. Moreover, softer foam can be produced without having to apply a too low NCO index resulting in better mechanical properties and in particular in a lower compression set. Finally, higher foam densities can be achieved with an isocyanate component having a lower functionality so that the hardness of these foams can be reduced. | 2012-02-16 |
20120041091 | Radioactive ray-curable liquid resin composition for use in optical stereolithography, and optically shaped article produced by curing the composition - The present invention aims to provide a radiation-curing liquid resin composition for optical tridimensional modeling having good storage stability. The suitable radiation-curing liquid resin composition for optical tridimensional modeling of the present invention includes a compound represented by the below general formula (1), a compound having phenolic hydroxyl group, a cationic polymerizable compound, a radical polymerization initiator, a radical polymerizable compound, one or more sulfur compound selected from the group consisting of 2-mercaptobenzothiazole, 2-(4-morpholinodithiobenzothiazole, diisopropylxantogendisulfide and diphenyldisulfide, a polyether polyol compound. | 2012-02-16 |
20120041092 | OPAQUE WATERBORNE UV SCRATCH RESISTANT COATINGS - A coating composition includes a UV curable film forming resin; a thixotropic and/or pseudoplastic anti-settling agent selected from at least one of an amine salt of a synthetic wax, a microcrystalline cellulose compound (MCC), a urea urethane, or a urethane enzymatically modified starch; a mar/scratch resistant additive selected from at least one of a mineral abrasive, glass particles, and ceramic particles; and water. | 2012-02-16 |
20120041093 | POLYMERIZABLE COMPOSITIONS - The invention relates to the use of triazenes of formula (I) wherein Q is a direct bond or a bivalent radical —(CR | 2012-02-16 |
20120041094 | HIGH TEMPERATURE MELTING - The present invention relates to methods for making wear and oxidation resistant polymeric materials by high temperature melting. The invention also provides methods of making medical implants containing cross-linked antioxidant-containing tough and ductile polymers and materials used therewith also are provided. | 2012-02-16 |
20120041095 | APPARATUS AND METHOD OF REACTING POLYMERS BY EXPOSURE TO UV RADIATION TO PRODUCE INJECTABLE MEDICAL DEVICES - Cross-linked compositions include a first precursor functionalized with a first reactive member and a second precursor functionalized with a second reactive member, the first and second reactive members covalently bonding with each other when exposed to UV radiation. The compositions are useful in a variety of surgical and wound treatment applications. | 2012-02-16 |
20120041096 | ENERGY-RAY-CURABLE ELASTOMER COMPOSITION, MATERIAL FOR GASKET, GASKET, AND HARD DISK DEVICE - Provided is an energy ray-curable elastomer composition which can increase the inter-crosslinking point molecular weight without changing the kind of an energy ray-curable compound before cured and which provides an oligomer-cured substance having a braking elongation compatible with a processability, to be specific, an energy ray-curable elastomer composition containing (A) an energy ray-curable compound having a (meth)acryloyl group and (B) a polythiol compound having 2 to 6 mercapto groups in a molecule, wherein a functional group number ratio of the (meth)acryloyl group in the above composition to the mercapto group in the component (B) is 100:0.1 to 100:5n (n is the number of the mercapto group in a molecule of the polythiol compound). Further, provided are a material for a gasket containing the energy ray-curable elastomer composition described above which provides a gasket enhancing a braking elongation without damaging a processability and other necessary physical properties and making it possible to inhibit cracking, breaking and the like from being caused, a gasket comprising a substance obtained by curing the above material for a gasket by an energy ray and a hard disk device prepared by using the above gasket. | 2012-02-16 |
20120041097 | SILICONE-CONTAINING PREPOLYMERS WITH DANGLING HYDROPHILIC POLYMER CHAINS - The invention provide a new class of silicone-containing prepolymers containing dangling hydrophilic polymer chains. This class of silicone-containing prepolymer is capable of being actinically crosslinked to form a silicone hydrogel material with a hydrophilic surface without post curing surface treatment. The present invention is also related to silicone hydrogel contact lenses made from this class of silicone-containing prepolymers and to methods for making the silicone hydrogel contact lenses. | 2012-02-16 |
20120041098 | RUBBER COMPOSITION FOR A TIRE CONTAINING EPOXIDE NATURAL RUBBER AND A PLASTICIZING RESIN - The present invention relates to a rubber composition based on at least an epoxidized natural rubber—, a reinforcing filler and, as plasticizing agent, an alpha-methylstyrene polymer resin. The invention also relates to the use of such a composition for the manufacture of a tyre tread exhibiting an improved compromise of properties with respect to grip on wet ground and rolling resistance. | 2012-02-16 |
20120041099 | TIRE PUNCTURE SEALANT - A tire puncture sealant including a rubber latex and/or a resin emulsion, and an acetylene alcohol and/or a derivative thereof. | 2012-02-16 |
20120041100 | MOLECULAR MISCIBLE BLEND SOLUTION OF AROMATIC POLYAMIDE AND NON-CRYSTALLINE POLYMER, METHOD FOR PREPARING THE SAME, AROMATIC POLYAMIDE BLEND FIBER USING THE SAME AND METHOD FOR DYING THE SAME - Disclosed are a molecular miscible blend solution of aromatic polyamide which is composed of a homogeneous mixture of a highly crystalline para-aromatic polyamide polymer and a non-crystalline polymer and is optically anisotropic, a method for preparing the same, an aromatic polyamide blend fiber prepared from the same and a method for dying the fiber at room pressure. Disclosed is a molecular miscible blend solution of aromatic polyamide and a non-crystalline polymer, in which an aromatic polyamide polymer having repeat units represented by the following Formula (I) and polyvinylpyrrolidone at an amount of 5 to 100% of the weight of the aromatic polyamide are dissolved in a polar organic solvent containing an inorganic salt. | 2012-02-16 |
20120041101 | CATALYSIS OF EPOXY RESIN FORMULATIONS - The present invention relates to epoxy resin formulations comprising a specific catalyst mixture for enhancing the reactivity thereof. | 2012-02-16 |
20120041102 | NOVEL EPOXY RESIN AND EPOXY RESIN COMPOSITION COMPRISING THE SAME - The present invention relates to a novel epoxy resin having improved heat-resistance, thermal expansion properties and processability, and to a thermosetting resin composition comprising the same. To this end, the present invention provides an epoxy resin of Chemical Formula 1 as disclosed in the Description, an epoxy resin composition comprising the same, and a packaging, substrate and transistor formed thereof. When a composition that contains an epoxy resin with a specific side functional group according to the present invention and/or an epoxy resin with a specific core structure is cured, a filler forms a strong chemical bond with the epoxy resin, thereby maximizing filling effects of the filler for the epoxy resin. Moreover, with the specific core structure, heat resistance and heat expansion properties of a cured product are substantially improved (CTE is reduced), and enhanced glass transition properties, strength and processability are demonstrated. | 2012-02-16 |
20120041103 | Fast Hydraulic Binder for Parts and Constructions Made of Concrete Containing A Calcium Salt - A fast hydraulic binder comprising cement, at least one first superplasticizer, a calcium salt, and at least one second superplasticizer different from the first superplasticizer and comprising a main chain and pendant groups connected to the main chain adapted so as to separate from the main chain in a basic medium, wherein the result is that the second plasticizer has a fluidifying action which increases at least temporarily over time in a basic medium. | 2012-02-16 |
20120041104 | Dispersant Comprising Copolymer Mixture - The invention relates to a polymer composition containing 3 to 95% by weight of a copolymer H and 3 to 95% by weight of a copolymer K, the copolymers H and K each having polyether macromonomer structural units and acid monomer structural units, which are present in the copolymers H and K in each case in a molar ratio of 1:20 to 1:1, and at least 20 mol % of all structural units of the copolymer H and at least 25 mol % of all structural units of the copolymer K being present in each case in the form of acid monomer structural units, the polyether macromonomer structural units of the copolymers H and K having side chains containing in each case at least 5 ether oxygen atoms, the number of ether oxygen atoms per side chain of the polyether macromonomer structural units of the copolymers H and K varying in each case in such a way that the corresponding frequency distribution diagrams, in which the number of ether oxygen atoms per side chain of a polyether macromonomer structural unit is plotted in each case along the abscissae and the respectively associated frequencies for the copolymers H or K are plotted in each case along the ordinates, contain in each case at least 2 maxima whose abscissa values differ in each case by more than 7 ether oxygen atoms from one another, the frequency distribution diagrams of the copolymers H and K differing from one another in that the abscissa value of at least one maximum of the copolymer H differs in each case by more than 5 ether oxygen atoms from the abscissa values of all maxima of the copolymer K and/or that the arithmetic means of the ether oxygen atoms of the polyether macromonomer structural units of the copolymers H and K differ from one another by more than 5 ether oxygen atoms. | 2012-02-16 |
20120041105 | Dispersing Agent Containing Copolymer Mixture - The invention relates to a polymer composition containing 3 to 90% by weight of a copolymer H and 3 to 90% by weight of a copolymer K, the copolymers H and K each having polyether macromonomer structural units and acid monomer structural units, which are present in the copolymers H and K in each case in a molar ratio of 1:20 to 1:1, and at least 20 mol % of all structural units of the copolymer H and at least 25 mol % of all structural units of the copolymer K being present in each case in the form of acid monomer structural units, at least 60 mol % of the polyether macromonomer structural units of the copolymer H being represented by the isoprenol polyether derivative structural units and at least 60 mol % of the polyether macromonomer structural units of the copolymer K being represented by the vinyloxy polyether derivative structural units. | 2012-02-16 |
20120041106 | Dispersing Agent Containing Copolymer Mixture - The invention relates to a polymer composition containing 5 to 95% by weight of a copolymer H and 2 to 60% by weight of a copolymer K, the copolymers H and K each having polyether macromonomer structural units and acid monomer structural units, which are present in the copolymers H and K in each case in a molar ratio of 1:20 to 1:1, and at least 20 mol % of all structural units of the copolymer H and at least 25 mol % of all structural units of the copolymer K being present in each case in the form of acid monomer structural units, the polyether macromonomer structural units of the copolymer H having side chains containing in each case at least 5 ether oxygen atoms, the number of ether oxygen atoms per side chain of the polyether macromonomer structural units of the copolymer H varying in such a way that the corresponding frequency distribution diagram, in which the number of ether oxygen atoms per side chain of a polyether macromonomer structural unit is plotted along the abscissa and the associated frequency for the copolymer H is plotted along the ordinate, contains at least 2 maxima. | 2012-02-16 |
20120041107 | WOOD FILLER COMPOSITION WITH KEVLAR - A wood filling composition that includes a predetermined weight percent of ceramic microspheres and a predetermined weight percent of polyaramid fiber, such as KEVLAR. This composition may also include a predetermined weight percent of at least one colored pigment; at least one bactericide; at least one mildewcide; at least one surfactant; at least one dispersant; at least one freeze-thaw stabilizer; at least one defoamer; at least one polymer; at least one adhesion promoter; at least one thickener; at least one filler; water; wood flour, glass bubbles; or combinations thereof. | 2012-02-16 |
20120041108 | STABILIZED DYNAMICALLY VULCANIZED THERMOPLASTIC ELASTOMER COMPOSITIONS USEFUL IN FLUID BARRIER APPLICATIONS - A stabilized, dynamically vulcanized thermoplastic elastomer composition comprising dispersed dynamically vulcanized particles of at least one first elastomer or rubber comprising halogenated isobutylene-containing elastomer and dispersed particles of at least one second elastomer or rubber comprising at least one functional group capable of reacting with and grafting to a polyamide, the particles of the at least one first and at least one second elastomers dispersed in a continuous thermoplastic polyamide or nylon resin matrix comprising at least one nylon homopolymer, nylon copolymer or mixture thereof, the composition or the at least one first elastomer further comprising at least one stabilizer against degradation induced by exposure to actinic, particularly ultraviolet, radiation. The compositions are preferably produced in a mixing extruder and are suitable for producing durable, flexible, thermoplastic elastomer fluid barrier films or layers useful in industrial articles such as vehicle tire innerliners and hoses. | 2012-02-16 |
20120041109 | Method Of Improving Film Processing And Injection Molding Of Polyhydroxyalkanoate Polymers - Processing and improvements in processing of polyhydroxyalkanoate polymer films, sheet, injection moldings, thermoforms, and blow moldings are provided, by use of particular types of calcium carbonate. Methods for using the calcium carbonates in processing of polyhydroxyalkanoate polymers are also disclosed, as well as polyhydroxyalkanoate polymer compositions comprising the calcium carbonates, and articles made therefrom. | 2012-02-16 |
20120041110 | LATEX COATING COMPOSITIONS INCLUDING CARBOXY ESTER KETAL COALESCENTS, METHODS OF MANUFACTURE, AND USES THEROF - A latex coating composition is disclosed, comprising a latex polymer binder; water; and a ketal adduct of formula (1) | 2012-02-16 |
20120041111 | Spherical radiofrequency-encoded beads - The invention relates to a method for the production of a composition comprising a plurality of spherical radiofrequency-identifiable (RF-tagged) polymeric beads as well the composition as such. The invention also relates to an apparatus for analyzing, identifying or sorting as well as treating a plurality of spherical radiofrequency-identifiable beads, and further to a method for recording individual reaction steps involved in the step-wise synthesis of a chemical compound on a radiofrequency-detectable bead. The beads of the composition are substantial spherical and preferably comprises a hydrophilic polymer material so as to prevent fouling. | 2012-02-16 |
20120041112 | PROCESS FOR IMPROVING THE STORAGE STABILITY OF AQUEOUS COMPOSITE-PARTICLE DISPERSIONS - The invention provides a process for improving the storage stability of aqueous composite-particle dispersions and of aqueous formulations comprising them. | 2012-02-16 |
20120041113 | ADHESIVE COMPOSITION FOR ORGANIC FIBER CORDS, RUBBER-REINFORCING MATERIAL USING SAME, TIRE AND BONDING METHOD - Provided is an adhesive composition for organic fiber cords which does not contain resorcinol and formaldehyde and has a good adhesive property and is good for the environment, particularly for the work environment, and a rubber reinforcing material, a tire and a bonding method using the same. Also provided is an adhesive composition for organic fiber cords which contains (blocked) isocyanate compound and/or amine-based curing agent (A), epoxy compound (B), rubber latex(C), and a rubber reinforcing material, a tire and a bonding method using the same. The ratio of the mass of the (blocked) isocyanate compound and/or amine curing agent (A) a to the mass of the epoxy compound (B) b (the mass of (blocked) isocyanate compound and/or amine curing agent/the mass of epoxy compound), a/b is preferably not smaller than 0.1 and not larger than 30. | 2012-02-16 |
20120041114 | RESIN COMPOSITION AND RESIN MOLDED ARTICLE - A resin composition includes a polylactic acid, a monocarbodiimide compound and a phosphazene. | 2012-02-16 |
20120041115 | Pelletized Low Molecular Weight Brominated Aromatic Polymer Compositions - Novel polymer compositions of specified formula are converted into pellets of this invention by process technology provided by this invention. By forming a melt blend of a polymer of such polymer compositions together with a modest amount of at least one thermoplastic polymer of at least one monoolefmic monomer having 2-12 carbon atoms per molecule, and converting the melt blend into pellets as described herein, pellets can be formed produce during production, handling, and use, almost no “fines” or air-entrainable dusts. The pellets have an array of additional superior properties and characteristics. | 2012-02-16 |
20120041116 | FORMED ARTICLE, METHOD FOR PRODUCING SAME, ELECTRONIC DEVICE MEMBER, AND ELECTRONIC DEVICE - Disclosed is a formed article comprising an ion-implanted layer obtained by implanting ions of a silicon compound into a polymer layer. Also disclosed are: a method of producing the formed article, the method comprising implanting ions of a silicon compound into a surface of a polymer layer of a formed body that includes the polymer layer in its surface; an electronic device member comprising the formed article; an electronic device comprising the electronic device member. Consequently, the present invention provides: a formed article which has excellent gas barrier capability, bendability and surface flatness; a method of producing the formed article, an electronic device member comprising the formed article; an electronic device comprising the electronic device member. | 2012-02-16 |
20120041117 | Binder Compound - The present invention relates to a binder compound based on natural oil, polymer and resin. Such binder compounds can for example be used in roof covering membranes as an environmentally friendly alternative to bituminous roof covering membranes. | 2012-02-16 |
20120041118 | POLYVINYL ALCOHOL-BASED RESIN COMPOSITION - The present invention provides a polyvinyl alcohol-based resin (PVOH-based resin) composition having less coloration from melt processing and having high aging stability of the melt viscosity. The present invention relates to a polyvinyl alcohol-based resin composition comprising a polyvinyl alcohol-based rein having a structural unit represented by the following formula (1) and having an absorbance of 0.1 to 0.3 of 280 nm in an ultraviolet absorbance spectrum as a 4 mass % aqueous solution, a carboxylic acid and an alkaline (earth) metal salt, wherein when an aqueous solution of the polyvinyl alcohol-based resin composition is prepared so as to have a content of the polyvinyl alcohol-based resin of 4 mass %, the pH of the aqueous solution at 20° C. is from 5.5 to 7: | 2012-02-16 |
20120041119 | SOFT THERMOPLASTIC POLYURETHANE BASED ON THE ESTER OF A TRICARBOXYLIC ACID - The invention refers to a thermoplastic polyurethane produced from at least an organic diisocyanate and a compound which is reactive toward isocyanates, wherein the polyurethane comprises the ester of a tricarboxylic acid with at least one alcohol and wherein all acid groups of the tricarboxylic acid are esterified with an alcohol. The invention further refers to a process for producing the respective polyurethane, products comprising this thermoplastic polyurethane and the use of the ester of a tricarboxylic acid as plasticizer in thermoplastic polyurethanes. | 2012-02-16 |
20120041120 | THERMALLY CURABLE RESIN COMPOSITION FOR PROTECTIVE FILM - The present invention provides an overcoat film which has excellent degree of planarization by optimizing the molecular weight of a binder resin included in a thermally curable resin composition for a protective film and the content of each component including the same. In a color filter according to the present invention, it is not necessary to light up all the red, green, and blue (RGB) pixels for eliciting a white light and perform a separate application process of a white portion because an overcoat film according to the present invention may serve as the white portion. | 2012-02-16 |
20120041121 | METHOD FOR MANUFACTURING POROUS STRUCTURE AND METHOD FOR FORMING PATTERN - A pattern forming material contains a block copolymer or graft copolymer and forms a structure having micro polymer phases, in which, with respect to at least two polymer chains among polymer chains constituting the block copolymer or graft copolymer, the ratio between N/(Nc−No) values of monomer units constituting respective polymer chains is 1.4 or more, where N represents total number of atoms in the monomer unit, Nc represents the number of carbon atoms in the monomer unit, No represents the number of oxygen atoms in the monomer unit. | 2012-02-16 |
20120041122 | Polyvinylidene Fluoride Resin Composition, White Resin Film, And Backsheet For Solar Cell Module - A polyvinylidene fluoride resin composition containing a polyvinylidene fluoride resin and titanium oxide, wherein the content of the titanium oxide is 5 to 100 parts by weight per 100 parts by weight of the polyvinylidene fluoride resin, the resin composition contains, as a heat stabilizer, at least one compound selected from the group consisting of calcium polyhydroxymonocarboxylates, calcium salts of aliphatic carboxylic acids having 5 to 30 carbon atoms, calcium carbonate, calcium hydroxide, zinc oxide and magnesium oxide in a proportion of 0.1 to 20 parts by weight, and a weight ratio of the titanium oxide to the heat stabilizer is 100:1 to 3:1. | 2012-02-16 |
20120041123 | METHOD FOR PRODUCING SLURRY COMPOSITION - The present invention provides a method for producing a slurry composition which realizes excellent dispersibility through simple steps. In addition, the present invention provides a slurry composition produced using this method. | 2012-02-16 |